Who owns CONDUIT PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Conduit Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Conduit Pharmaceuticals stock

Who bought or sold CONDUIT PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Highbridge Capital Management 1.2M $98M 3% Dec 2023
 View chart
Polar Securities 950k $66k 0% Dec 2023
 View chart
Saba Capital Management 765k $57k 0% Dec 2023
 View chart
MMCAP International Inc. SPC 700k $49k 0% Dec 2023
 View chart
Exos TFP Holdings 555k $38k 0% Dec 2023
 View chart
Walleye Trading Advisors 516k $36k 191% Dec 2023
 View chart
D. E. Shaw & Co 375k $30k 0% Dec 2023
 View chart
Walleye Trading 290k $20k 305% Dec 2023
 View chart
Wolverine Asset Management 286k $20k 16% Dec 2023
 View chart
CNH Partners 226k $16k -16% Dec 2023
 View chart
Cowen And Company 202k $14k -65% Dec 2023
 View chart
Whitebox Advisors 200k $14k 0% Dec 2023
 View chart
Rivernorth Capital Management 200k $10k 0% Dec 2023
 View chart
Context Capital Management 129k $8.9M 0% Dec 2023
 View chart
Kim 100k $7.5k 0% Dec 2023
 View chart
Hudson Bay Capital Management 73k $5.1k -63% Dec 2023
 View chart
Millennium Management 35k $2.4k 0% Dec 2023
 View chart

Who sold out of Conduit Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Arena Investors Sep 2023 250k $11k
SkyView Investment Advisors Sep 2023 150k $7.0k
Brooklyn Capital Management Sep 2023 95k $4.3k